It's 2024 and women are still making less money than men. Photo by LinkedIn Sales Solutions on Unsplash

It's 2024 and women are still making less money than men, thus keeping the unfortunate reality of the wage gap alive. But at least in Houston, the wage gap isn't as bad as other Texas cities, according to a new earnings study by Chamber of Commerce.

Houston ranked No. 142 on the list, which examined earnings for full-time workers in 170 of the most populous cities in the United States.

The study found that, in 2024, men in Houston are currently making $4,474 more than women — a figure that's significantly lower than the national wage gap, which is a little over $11,000.

The U.S. city with the worst gender pay gap is none other than Frisco, a Dallas suburb. Men in Frisco are currently making a staggering $52,216 more than women, which is more than $12,000 more than the gap in 2023.

Also in North Texas, McKinney remained in the No. 5 spot for the second consecutive year. McKinney men make $24,568 more than women, which is a $4,400 decrease year-over-year. Plano's gender wage gap has worsened since 2023: The Dallas suburb is now listed among the top 10 worst pay gaps in the U.S., climbing to No. 6. The study says the Plano's wage gap is now $23,415, or nearly $2,300 more than last year.

Statewide gender pay gap

Chamber of Commerce found that Texas' gender pay gap has increased since last year; The 2023 study found that women made nearly $11,000 less than men, and that discrepancy has widened in 2024 to nearly $12,000.

However, Texas' ranking has improved 10 spots from No. 29 last year to No. 19 this year.

For added context, New Hampshire has the No. 1 worst pay gap in the nation, with men making over $18,000 more than women.

Other Texas cities that earned spots in the report are:

  • No. 20 – Amarillo
  • No. 22 – Laredo
  • No. 24 – Austin
  • No. 30 – Corpus Christi
  • No. 31 – Pasadena
  • No. 33 – Irving
  • No. 52 – Lubbock
  • No. 59 – El Paso
  • No. 65 – Grand Prairie
  • No. 81 – Fort Worth
  • No. 118 – Dallas
  • No. 121 – San Antonio
  • No. 125 – Arlington
  • No. 167 – Brownsville
  • No. 168 – Garland

------

This article originally ran on CultureMap.

A new study finds how Houston — and other Texas cities — rank in terms of the pay gap between male and female workers. Photo via Getty Images

How Houston stacks up when it comes to its gender pay gap

mind the gap

Pi wasn't the only thing celebrated yesterday on March 14. Equal Pay Day is also celebrated on the same day — a day to examine the decades of advocacy to extinguish the pay gap between men and women.

Unfortunately, nationwide the gap is still large. The latest Census Bureau says women make 18 percent less money than men do. We know the numbers for Texas and several of its cities, thanks to a new study by small biz experts Chamber of Commerce. They investigated the earnings for full-time workers in 170 of the most populous cities in the United States.

The analysis found that Texas has the 29th largest pay gap out of all 50 states, with women making nearly $11,000 less than men. Texas women can be glad they don’t live in Wyoming, which has the largest pay gap of the states at almost $19,000.

The city with the largest gender pay gap in the United States is Sunnyvale, California, home to Silicon Valley, with an earnings difference of $40,584 between men and women. Actually, California cities make up half of the top 10 largest gender pay gaps.

Texas, however, has two towns in the top 10. Coming in at No. 2 is Frisco and McKinney lands at No. 5. Frisco men make nearly $40,000 more than women, while McKinney men make $29,000 more than women. Just outside the top 10 is Plano at No. 12, with their gender pay gap adding up to $20,736.

How does Houston fair? Not too shabby, actually. The Bayou City landed at the No. 114 spot out of 170 of the most-populated cities in the U.S. Dallas actually has the smallest gender pay gap in Texas, coming in at No. 166 with just $192 between full-time working men and women.

Here's how the rest of Texas ranks:

  • No. 13 – Austin
  • No. 25 – Pasadena
  • No. 30 – Lubbock
  • No. 45 – Fort Worth
  • No. 70 – Irving
  • No. 71 – Corpus Christi
  • No. 74 – San Antonio
  • No. 89 – Arlington
  • No. 93 – Grand Prairie
  • No 97 – El Paso
  • No. 101 – Laredo
  • No. 110 – Amarillo
  • No. 125 – Brownsville
  • No. 134 – Garland

The full study can be found on chamberofcommerce.org.

------

This article originally ran on CultureMap.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Axiom Space-tested cancer drug advances to clinical trials

mission critical

A cancer-fighting drug tested aboard several Axiom Space missions is moving forward to clinical trials.

Rebecsinib, which targets a cancer cloning and immune evasion gene, ADAR1, has received FDA approval to enter clinical trials under active Investigational New Drug (IND) status, according to a news release. The drug was tested aboard Axiom Mission 2 (Ax-2) and Axiom Mission 3 (Ax-3). It was developed by Aspera Biomedicine, led by Dr. Catriona Jamieson, director of the UC San Diego Sanford Stem Cell Institute (SSCI).

The San Diego-based Aspera team and Houston-based Axiom partnered to allow Rebecsinib to be tested in microgravity. Tumors have been shown to grow more rapidly in microgravity and even mimic how aggressive cancers can develop in patients.

“In terms of tumor growth, we see a doubling in growth of these little mini-tumors in just 10 days,” Jamieson explained in the release.

Rebecsinib took part in the patient-derived tumor organoid testing aboard the International Space Station. Similar testing is planned to continue on Axiom Station, the company's commercial space station that's currently under development.

Additionally, the drug will be tested aboard Ax-4 under its active IND status, which was targeted to launch June 25.

“We anticipate that this monumental mission will inform the expanded development of the first ADAR1 inhibitory cancer stem cell targeting drug for a broad array of cancers," Jamieson added.

According to Axiom, the milestone represents the potential for commercial space collaborations.

“We’re proud to work with Aspera Biomedicines and the UC San Diego Sanford Stem Cell Institute, as together we have achieved a historic milestone, and we’re even more excited for what’s to come,” Tejpaul Bhatia, the new CEO of Axiom Space, said in the release. “This is how we crack the code of the space economy – uniting public and private partners to turn microgravity into a launchpad for breakthroughs.”